EMEA-000332-PIP02-17

Key facts

Invented name
  • Briviact (in Italy: Nubriveo)
  • Briviact
Active substance
Brivaracetam
Therapeutic area
Neurology
Decision number
P/0052/2018
PIP number
EMEA-000332-PIP02-17
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of paediatric epilepsy syndromes
Route(s) of administration
Oral use
Contact for public enquiries
UCB Pharma S.A.
Tel. +32 25599314
E-mail: Peter.Dedeken@ucb.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
2 ratings